Publications by authors named "Alfredo Vozza"

Claim this Profile
P
Predictive factors of body weight loss in patients with type 2 diabetes treated with GLP-1 receptor agonists: a 52-week prospective real-life study.
Alfredo Vozza, Domenico Triggiani, Margherita Fanelli, Giuseppe Lisco, Deborah Coletto

Front Endocrinol (Lausanne)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Prediction of In-Hospital Mortality in Patients with Acute Infections: Development of the Acute Severity Infection Score (ASIs).
Alessio Comitangelo, Alfredo Vozza, Giovanna Ditaranto, Giuseppe Re, Ada Berloco

Infect Dis Ther· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors Improve Renal Resistive Index in Patients With Type 2 Diabetes: A 26-Week Prospective Observational Real-Life Study.
Alfredo Vozza, Sara Volpe, Carlo Custodero, Valentina Colaianni, Valentina Lavarra

J Diabetes Res· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sodium-Glucose Cotransporter 2 Inhibitors Improve Body Composition by Increasing the Skeletal Muscle Mass/Fat Mass Ratio in Patients with Type 2 Diabetes: A 52-Week Prospective Real-Life Study.
Sara Volpe, Alfredo Vozza, Giuseppe Lisco, Margherita Fanelli, Davide Racaniello

Nutrients· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of COVID-19 Lockdown on Patients with Type 2 Diabetes Mellitus: A Brief Report.
Alfredo Vozza, Erasmo Porfido, Alessandra Delvino, Carlo Custodero, Giuseppe Lisco

Endocr Metab Immune Disord Drug Targets· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvement of Left Ventricular Global Longitudinal Strain after 6-Month Therapy with GLP-1RAs Semaglutide and Dulaglutide in Type 2 Diabetes Mellitus: A Pilot Study.
Paolo Basile, Andrea Igoren Guaricci, Giuseppina Piazzolla, Sara Volpe, Alfredo Vozza

J Clin Med· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and clinical benefits of new anti-diabetic drugs: A real life experience.
Giuseppina Piazzolla, Alfredo Vozza, Sara Volpe, Alessandro Bergamasco, Vincenzo Triggiani

Open Med (Wars)· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Once-Weekly Semaglutide Induces an Early Improvement in Body Composition in Patients with Type 2 Diabetes: A 26-Week Prospective Real-Life Study.
Sara Volpe, Giuseppe Lisco, Davide Racaniello, Margherita Fanelli, Valentina Colaianni, Alfredo Vozza

Nutrients· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical phenotyping in sarcoidosis management.
Giuseppe Domenico Rana, Miriana d'Alessandro, Luigi Rizzi, Laura Bergantini, Paolo Cameli, Alfredo Vozza

Sarcoidosis Vasc Diffuse Lung Dis· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis